Found: 10
Select item for more details and to access through your institution.
Tumor localization by Prostate Imaging and Reporting and Data System (PI-RADS) version 2.1 predicts prognosis of prostate cancer after radical prostatectomy.
- Published in:
- Scientific Reports, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41598-023-36685-1
- By:
- Publication type:
- Article
Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer.
- Published in:
- Cancers, 2022, v. 14, n. 23, p. 5823, doi. 10.3390/cancers14235823
- By:
- Publication type:
- Article
Prognostic factors influencing overall survival in de novo oligometastatic prostate cancer patients.
- Published in:
- Prostate, 2020, v. 80, n. 11, p. 850, doi. 10.1002/pros.24016
- By:
- Publication type:
- Article
Prognostic value of an inflammatory index for patients with metastatic castration‐resistant prostate cancer.
- Published in:
- Prostate, 2020, v. 80, n. 7, p. 559, doi. 10.1002/pros.23969
- By:
- Publication type:
- Article
How many bone metastases may be defined as high‐volume metastatic prostate cancer in Asians: A retrospective multicenter cohort study.
- Published in:
- Prostate, 2020, v. 80, n. 5, p. 432, doi. 10.1002/pros.23958
- By:
- Publication type:
- Article
Testosterone bounce predicts favorable prognoses for prostate cancer patients treated with degarelix.
- Published in:
- Prostate, 2024, v. 84, n. 7, p. 636, doi. 10.1002/pros.24679
- By:
- Publication type:
- Article
Clinical utility of the prognostic nutritional index in patients with metastatic hormone‐sensitive prostate cancer: A retrospective, multicenter, cohort study.
- Published in:
- Prostate, 2023, v. 83, n. 16, p. 1610, doi. 10.1002/pros.24619
- By:
- Publication type:
- Article
The LAT1 inhibitor JPH203 suppresses the growth of castration‐resistant prostate cancer through a CD24‐mediated mechanism.
- Published in:
- Cancer Science, 2024, v. 115, n. 7, p. 2461, doi. 10.1111/cas.16191
- By:
- Publication type:
- Article
L‐type amino acid transporter 1 inhibitor JPH203 prevents the growth of cabazitaxel‐resistant prostate cancer by inhibiting cyclin‐dependent kinase activity.
- Published in:
- Cancer Science, 2024, v. 115, n. 3, p. 937, doi. 10.1111/cas.16062
- By:
- Publication type:
- Article
Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.
- Published in:
- Cancer Science, 2021, v. 112, n. 9, p. 3871, doi. 10.1111/cas.14991
- By:
- Publication type:
- Article